Wednesday 4th March 2020
Last Tuesday’s Westminster Forum focussed on the next steps in prevention, innovation and delivery of care for cardiovascular disease.
Wednesday 29th January 2020
We are are pleased to see valve disease research identified in the Top 10 research priorities compiled by Heart Surgery Priority Setting Partnership at the University of Leicester Medical School.
Friday 17th January 2020
Hull University Teaching Hospital NHS Trust had its first year of administrating TAVI to patients in the region of Hull and East Yorkshire. Mr David Morris, 86, received the first TAVI in March of 2019 under Dr Raj Chelliah, Consultant Cardiologist, and his team.
Wednesday 9th October 2019
Professor Jan Kovac, an interventional cardiologist at Glenfield Hospital in Leicester, presented a live Transcatheter aortic valve implantation procedure (TAVI) on the 9th of October. As part of the International Structural Heart Disease conference.
Thursday 19th September 2019
We're proud to be launching our report ‘State of the Nation: Heart Valve Disease in Wales’ today during European Heart Valve Disease Awareness Week. The new report sets outs recommendations for early diagnosis and treatment services in Wales.
Wednesday 18th September 2019
Today, we launch the Unwarranted Variation Report and we believe that the recommendations in this report can help to remedy the problem of inequalities of access to treatment and highlight opportunities in delivering optimal treatment of heart valve disease.
Monday 11th March 2019
LONDON, 11 March 2019 - Heart Valve Voice has launched our report ‘Towards a Heart Healthy Future: A Gold Standard in the Diagnosis, Treatment and Management of Heart Valve Disease in Adults' at the 2019 Society for Cardiothoracic Surgery Conference.
Tuesday 5th February 2019
On Wednesday the 23rd of January, Heart Valve Voice Chief Executive, Wil Woan was invited by NICE to share his insights and be a part of the development process for the 2019 NICE guidelines for heart valve disease. It was a brilliant opportunity to represent the patient voice amongst the esteemed group of clinicians and leading policy makers in attendance.